Incyte advertising spend, FY2025

Incyte (INCY) reported $156M of advertising expense for the fiscal year ended Dec 31, 2025. That is 3.0% of revenue of $5.1B. Down 22.3% from FY2024. Formerly Incyte Genomics and Incyte Pharmaceuticals.

Ad spend, FY2025
$156M
year ended Dec 31, 2025
Change vs prior year
-22.3%
vs FY2024
Share of revenue
3.0%
of $5.1B revenue
Rank by ad spend
#261
of 458 companies

Key facts

  • Ad spend is 5.4x its FY2020 level ($28.9M), faster than revenue (1.9x).
  • The highest year on file is FY2023 at $222M; FY2025 is 30% below it.
  • Largest increase +197.6% in FY2022; largest cut -22.3% in FY2025.
  • Ad spend has fallen 2 years in a row.
  • Ad spend is 3.0% of revenue, up from 1.1% in FY2020.
  • Incyte spends more on advertising than 43% of the 458 US-listed companies tracked. Its ad-to-revenue ratio is below the median of 4.5%.

Ad spend by fiscal year

$0 $100M $200M $300M FY2018 (ended 2018-12-31): $10.6M 2018 FY2019 (ended 2019-12-31): $15.3M 2019 FY2020 (ended 2020-12-31): $28.9M 2020 FY2021 (ended 2021-12-31): $66M 2021 FY2022 (ended 2022-12-31): $196M 2022 FY2023 (ended 2023-12-31): $222M 2023 FY2024 (ended 2024-12-31): $201M 2024 FY2025 (ended 2025-12-31): $156M 2025 $156M

Ad spend as % of revenue

0% 2% 4% 6% 8% FY2018 (ended 2018-12-31): 0.6% 2018 FY2019 (ended 2019-12-31): 0.7% 2019 FY2020 (ended 2020-12-31): 1.1% 2020 FY2021 (ended 2021-12-31): 2.2% 2021 FY2022 (ended 2022-12-31): 5.8% 2022 FY2023 (ended 2023-12-31): 6.0% 2023 FY2024 (ended 2024-12-31): 4.7% 2024 FY2025 (ended 2025-12-31): 3.0% 2025 3.0%

Ad spend in context, FY2025

Advertising was 11.3% of selling, general and administrative expense. Research and development spending was 13x advertising. Advertising equalled 10.3% of operating income.

Advertising $156M AdvertisingExpense
Selling, general and administrative $1.4B ad spend = 11.3%
Research and development $2.1B R&D = 13x ad spend
Operating income $1.5B ad spend = 10.3%
Net income $1.3B

Same fiscal year and filing as the ad spend. Selling and marketing and SG&A usually include advertising.

History

Download CSV
Fiscal year Period end Ad spend YoY Revenue Ad / revenue Tag Filing
FY2025 Dec 31, 2025 $156M -22.3% $5.1B 3.0% AdvertisingExpense 10-K Feb 10, 2026
FY2024 Dec 31, 2024 $201M -9.6% $4.2B 4.7% AdvertisingExpense 10-K Feb 10, 2026
FY2023 Dec 31, 2023 $222M +13.0% $3.7B 6.0% AdvertisingExpense 10-K Feb 10, 2026
FY2022 Dec 31, 2022 $196M +197.6% $3.4B 5.8% AdvertisingExpense 10-K Feb 10, 2025
FY2021 Dec 31, 2021 $66M +128.4% $3B 2.2% AdvertisingExpense 10-K Feb 13, 2024
FY2020 Dec 31, 2020 $28.9M +88.9% $2.7B 1.1% AdvertisingExpense 10-K Feb 7, 2023
FY2019 Dec 31, 2019 $15.3M +44.3% $2.2B 0.7% AdvertisingExpense 10-K Feb 8, 2022
FY2018 Dec 31, 2018 $10.6M n/a $1.9B 0.6% AdvertisingExpense 10-K Feb 9, 2021

Ad spend, revenue and the ratio come from the linked filing. YoY compares each year with the fiscal year directly before it, under the same tag. A gap, a change of tag or a change of fiscal year end leaves it blank.

What the figure is

Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).

Compared with similar spenders

The 6 companies closest to Incyte in latest-year ad spend.

Rank Company Ad spend Ad / revenue YoY Fiscal year
258 Wolverine World Wide $158M 8.4% +12.7% FY2025
259 Freshpet $158M 14.3% +23.6% FY2025
260 Petco Health & Wellness $158M 2.6% +1.1% FY2026
261 Incyte $156M 3.0% -22.3% FY2025
262 Simon Property Group $156M 2.4% +7.8% FY2025
263 eHealth $154M 27.7% -6.5% FY2025
264 Scotts Miracle-Gro $152M 4.5% +8.0% FY2025

Full ranking of 458 companies · Biggest cuts #14

Questions

How much does Incyte spend on advertising?

Incyte spent $156M on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Feb 10, 2026.

What percentage of revenue does Incyte spend on advertising?

3.0% of revenue in fiscal 2025 ($156M against $5.1B). The median across the 458 companies tracked is 4.5%.

Is Incyte spending more on advertising?

No. Ad spend fell 22.3% in fiscal 2025 from fiscal 2024. It has fallen 2 years in a row.

How does Incyte rank by advertising spend?

#261 of 458 US-listed companies with $50M or more in ad spend, ranked on each company's latest fiscal year.

Does Incyte spend more on advertising than on R&D?

No. In fiscal 2025 it spent $2.1B on research and development and $156M on advertising.

What does Incyte's advertising figure include?

Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).

Company and source

Filing
10-K for FY2025, filed Feb 10, 2026
Accession number
0000879169-26-000010
Company
INCYTE CORP, CIK 879169, SIC 8731 (Services-Commercial Physical & Biological Research)
Former names
Incyte Genomics, Incyte Pharmaceuticals
Headquarters
Wilmington, DE
Incorporated in
DE
Fiscal year ends
December 31
Listed on
Nasdaq
SEC filer status
Large accelerated filer
Data
SEC EDGAR XBRL company facts, retrieved Nov 18, 2026. Methodology.
Cite
Incyte advertising spend, FY2018-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Feb 10, 2026), retrieved Nov 18, 2026. https://io.trudov.com/company/incyte/advertising-spend/
Download
CSV, all years · CSV, all 458 companies